Skip to main content
Fig. 4 | Critical Care

Fig. 4

From: Continuous renal replacement therapy in COVID-19—associated AKI: adding heparin to citrate to extend filter life—a retrospective cohort study

Fig. 4

Kaplan–Meier estimate of filter clotting during the first filter use in continuous renal replacement therapy (CRRT) using anticoagulant citrate dextrose solution formula A (ACD-A), with and without unfractionated heparin (UH), among COVID-19-positive (COV +) patients (COV + ACD-A only group vs. COV + ACD-A + UH group)

Back to article page